VEEV · NYSE · Healthcare
Veeva Systems Inc. (VEEV) — Rank #245 by gross profitability (GP/assets 0.27) · ROE 12.2% · Piotroski F-Score 6 / 9.
As-of 2026-10-30 · CIK 0001393052 · all metrics point-in-time as of the filing date.
About
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
Show moreShow less
The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc.
was incorporated in 2007 and is headquartered in Pleasanton, California.
- Industry
- Health Information Services
- Sector
- Healthcare
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- January 31
- Website
- veeva.com
Company Snapshot
P/E and reverse DCF are the primary valuation lenses at this stage.
Market Cap
—
P/E (annual)
—
P/S (annual)
—
P/B
—
P/OCF (annual)
—
Shareholder Yield
—
Employees
7,928
Industry
Health Information Services
Exchange
NYSE
10/10
Flags passed
VEEV passes 10/10 quality flags
- PASSGross margin holding
- PASSDilution within 2%
- PASSDisclosure consistent
- PASSRevenue not declining
- PASSOperating margin holding
- PASSPasses safety gate
- PASSBalance sheet stable
- PASSNo competitive retreat
- PASSSBC not compressing margin
- PASSNo valuation convergence
Strengths Revenue growth accelerating · Operating leverage expanding · Deferred revenue growing · Sequential beat (rev + EPS)
No data FCF vs investment · Free cash flow — not counted as a pass.
A count of the 12 warning flags that could be evaluated. Unweighted: colour follows the worst flag.
Quality Profile
Profitability
1/1 passSafety
1/1 passCash Flow
1/1 passGrowth
2/2 passOperating margin expansion and free cash flow are the primary reads at this stage.
Profitability
Does it make money well?
No warning flags · GP/assets 29th percentile of 36 SIC 7372 peers
Gross profitability (GP / assets)
0.27
Primary signal (Novy-Marx).
29th pctl of 36 SIC 7372 peers
Return on equity
12.2%
Gross margin
75.5%
69th pctl of 36 SIC 7372 peers
Revenue growth (YoY)
16.3%
Gross margin improving
Margin trend vs prior year.
Operating Leverage
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Revenue vs COGS | ||||
| Revenue vs OpEx | ||||
| Op. Income vs Revenue |
Growth
Revenue CAGR (3Y)
14.0%
Revenue CAGR (5Y)
16.9%
Earnings CAGR (3Y)
23.1%
FCF CAGR (3Y)
—
Cash Flow Health
Is the cash real?
No data
Free cash flow
—
Operating cash flow minus capex.
Positive free cash flow
FCF vs net income
—
(FCF − net income) ÷ |net income|. Positive: cash above earnings. Negative: below.
FCF not below net income
Fails when free cash flow is below net income (yellow flag).
Accruals healthy
Cash-backed earnings.
SBC / revenue
14.8%
Stock-based comp intensity.
Balance Sheet Strength
Can it survive a storm?
No warning flags · net cash $7.24B, F-Score 6/9
Balance-sheet safety
Composite anti-fragile check.
Debt / equity
0.22
84th pctl of 32 SIC 7372 peers (best = lowest)
Current ratio
5.46×
91st pctl of 36 SIC 7372 peers
Quick ratio
5.32×
Net cash
$7.24B
Cash & equivalents minus total debt.
Piotroski F-Score
6 / 9
Fundamental-strength score (0-9).
Valuation
Is the price reasonable?
No warning flags
Capital allocation quality
Composite score
3.3 / 5
Lifecycle Phase History
Price History
Source filings on SEC EDGAR: 10-K annual reports · 10-Q quarterly reports